Drugs / Buprenorphine/naloxone
Buprenorphine/naloxone
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00078130 | Jul 2003 → Jan 2006 | substance-related disorder | University of Pennsylvania | Completed | Missed primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | buprenorphine-naloxone | “BACKGROUND: Primary care physicians with appropriate training may prescribe buprenorphine-naloxone (bup/nx) to treat opioid dependence in US office-based settings, where many...” PMID 22215271 ↗ Jan 2012 |
| Known as | Bup/Nal | “Objective: To examine predictors of opioid abstinence in buprenorphine/naloxone (Bup/Nal)-assisted psychosocial treatment for opioid-dependent youth.” PMID 22024000 ↗ Nov 2011 |
| Known as | bup/nx | “BACKGROUND: Primary care physicians with appropriate training may prescribe buprenorphine-naloxone (bup/nx) to treat opioid dependence in US office-based settings, where many...” PMID 22215271 ↗ Jan 2012 |